Funding round
Colossal Series A
Colossal, which works in genome editing and de-extinction services in Austin, raised $60M in a Series A round announced on 9 Mar 2022, led by At One Ventures. 13 firms took part. It is Colossal's second venture round on record; the one before was a Seed in May 2021.
$60M
Amount raised
Not disclosed
Post-money valuation
13
Investors
1 lead
Valuation
What this round says about the price
Colossal did not disclose a valuation in this round. It came 10 months after Colossal's Seed. It is 14% of the $425M Colossal has raised in the venture rounds on record. Colossal raised again 10 months later: a Series B round of $150M in Jan 2023. Its next priced round, a Series C in Jan 2025, valued it at $10.20B.
Colossal's funding rounds
Colossal has 4 venture rounds on record and 1 other deal. This one is highlighted.
- Seed 1 May 2021, led by Thomas Tull $15M
- Series A this round 9 Mar 2022, led by At One Ventures $60M
- Grant not a venture round 1 Oct 2022 amount not disclosed
- Series B 31 Jan 2023, led by United States Innovative Technology and Breyer Capital $150M
- Series C 17 Jan 2025, led by TWG Global $200M$10.20B post-money
Investors
Who put money in
At One Ventures led the round with 12 other firms.
Lead investor
- At One Ventures new investor
Also in the round
- Untamed Planet new investor
- Animoca Brands new investor
- Breyer Capital backs 85 venture-backed companies new investor
- backs 24 venture-backed companies new investor
- ARCH Venture Partners backs 99 venture-backed companies new investor
- backs 45 venture-backed companies new investor
- First Light Capital Group new investor
- backs 77 venture-backed companies new investor
- backs 32 venture-backed companies new investor
- backs 42 venture-backed companies new investor
- backs 8 venture-backed companies new investor
- backs 105 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to hiring, product development and scaling operations.
- Hiring
- Product development
- Scaling operations
Comparable rounds
How it compares
224 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $28M, and this round was 2.1 times the median. The closest in time, other companies' Series A rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 2 Mar 2022 | $67M | not disclosed | Red Tree Venture Capital and Canaan |
| Biotechnology | 10 Mar 2022 | $31M | not disclosed | Eir Ventures and BioMedPartners |
| Biotechnology | 30 Mar 2022 | $27M | not disclosed | not named |
| Biotechnology | 29 Mar 2022 | $18M | not disclosed | Panacea Venture |
| Biotechnology | 15 Mar 2022 | $14M | not disclosed | Alexandria Venture Investments and iGlobe |
| Biotechnology | 23 Mar 2022 | $8.7M | not disclosed | Claris Ventures and 2Invest |
| Biotechnology | 22 Mar 2022 | $8.0M | not disclosed | not named |
| Biotechnology | 1 Mar 2022 | $7.0M | not disclosed | not named |
Sources
Where this comes from
Reported by 3 sources.
Questions
Frequently asked
How much did Colossal raise in its Series A round?
Colossal raised $60M in its Series A round, announced in Mar 2022.
Who led Colossal's Series A round?
At One Ventures led it, with Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital and ARCH Venture Partners and 7 more.
What was Colossal's valuation at the Series A round?
It was not disclosed.
How does it compare with other Series A rounds in Biotechnology?
224 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $28M, and this round was 2.1 times the median.
Did Colossal raise again after this round?
Yes: a Series B round in Jan 2023 of $150M.